Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA. 1999 Jan 20; 281(3):235-42.